However, an in vitro study [17] revealed that IGF2R knockdown significantly reduced IGF2-related ERK1/2 phosphorylation, suggesting that the complex of IGF2 and IGF2R participates in cancer cell proliferation. The gene discussed is MAPK3; the disease is cancer.